The 2020 Tang Prize in Biopharmaceutical Science is jointly awarded to Drs. Charles Dinarello, Marc Feldmann and Tadamitsu Kishimoto, “for the development of cytokine-targeting biological therapies for treatment of inflammatory diseases” that brought a ray of hope to hundreds of thousands of patients debilitated by this degenerative condition. The Tang Prize FoundationExperimental Biology (EB) and National Cheng Kung University will co-host the 2020 Tang Prize Masters’ Forum on biopharmaceutical science, taking place from 9a.m. to 11:20 am. (GMT+8) Taiwan time, on September 22. 

This forum features three 2020 laureates speaking on the topic, “Targeting the Hyperactive Immune System, from Autoimmune Disease to Cytokine Storms,” keeping us abreast of the latest development in biomedical science in the age of coronavirus.

To engage audiences around the world, this forum will be livestreamed on the Foundation’s official website (https://www.tang-prize.org/en/week.php?cat=94 )

In addition, 2014 Tang Prize and 2018 Nobel Prize winners Dr. James P. Allison and Dr. Tasuku Honjo will also take part in the discussion, brainstorming with us to spot all the opportunities for the development of biopharmaceutical research that could be opened up because of this health crisis. 

1st Place ICIS-COVID-19 Video Contest Winner - Inflammatory Roles of Cytokines in COVID-19/SARS-CoV-2

The Role of Cytokines in COVID-19 – June 18th, 2020 9am-1.45pm Eastern – Virtual FREE Meeting

Collaborative Environment Released for COVID-19 Host Response Research

Enables and accelerates research leveraging BaseSpace Correlation Engine More

COVID-19 Vaccine & Therapeutics Tracker See the latest updates for vaccine and therapeutic drug developments for COVID-19. Check back for regular updates! New addition counters are reset every Monday by 11:59 PM ET. Updates added daily.
Can antivirals that target the host and not the virus improve outcomes for COVID-19 patients? Professor Eleanor Fish from the University of Toronto showed that treatment with interferon-alpha was beneficial in patients with SARS, and now shares early data on COVID-19. The webinar is moderated by Juan-Carlos Zuniga-Pflücker, the Chair of the Department of Immunology at the University of Toronto.
Professor Luke O'Neill, immunologist at Trinity College Dublin, has been advocating for people to wear face masks as he believes they are the key to halting the spread of coronavirus. He also thinks face masks will help us exit lockdown restrictions sooner.
Meike Dittmann, New York University School of Medicine & ICIS 2019 Christina Fleischmann Award winner is the virologist in this video: The Coronavirus Pandemic: 6 Experts, 6 Perspectives | The New Yorker
Northwestern University Professors Robert Lamb and Curt Horvath discuss the Coronavirus family and SARS-CoV-2, the causative agent of COVID-19.
Objective: A little story from the Italian COVID-19 Storms By Nicola Ivan Lorè
Elsevier gives full access to its content on its COVID-19 Information Center for PubMed Central and other public health databases to accelerate fight against coronavirus
Professor @florian_krammer discusses immunity to #COVIDー19